MaxCyte Share News (MXCT)

MaxCyte Information

Buy MXCT Shares
Add MXCT to Watchlist
Add MXCT to Alert

Share Price Information for MaxCyte (MXCT)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 370.00

Bid: 360.00

Ask: 380.00

Change: -10.00 (-2.63%)

Spread: 20.00 (5.556%)

Open: 378.00

High: 378.00

Low: 370.00

Prev. Close: 380.00

Last checked at -

UK earnings, trading statements calendar - next 7 days

Wed, 08th Mar 2023 15:54

Thursday 9 March
Aviva PLC	Full Year Results
ConvaTec Group PLC	Full Year Results
Digital 9 Infrastructure PLC	Full Year Results
Domino's Pizza Group PLC	Full Year Results
DS Smith PLC	Trading Statement
Endeavour Mining PLC	Full Year Results
Entain PLC	Full Year Results
Forterra PLC	Full Year Results
Franchise Brands PLC	Full Year Results
Hammerson PLC	Full Year Results
Harbour Energy PLC	Full Year Results
Hansard Global PLC	Half Year Results
Headlam Group PLC	Full Year Results
Informa PLC	Full Year Results
Kier Group PLC	Half Year Results
M&G PLC	Full Year Results
Network International Holdings PLC	Full Year Results
Oakley Capital Investments Ltd	Full Year Results
PageGroup PLC	Full Year Results
Seraphim Space Investment Trust PLC	Half Year Results
Spirax-Sarco Engineering PLC	Full Year Results
Volution Group PLC	Half Year Results
Wheaton Precious Metals Corp	Full Year Results
Friday 10 March
Allianz Technology Trust PLC	Full Year Results
Berkeley Group Holdings	Trading Statement
BP PLC	Full Year Results
FBD Holdings PLC	Full Year Results
Lancashire Holdings Ltd	Full Year Results
Mineral & Financial Investments Ltd	Half Year Results
Robert Walters PLC	Full Year Results
Monday 13 March
Direct Line Insurance Group PLC	Full Year Results
Fonix Mobile PLC	Half Year Results
HgCapital Trust PLC	Full Year Results
MTI Wireless Edge Ltd	Full Year Results
Nightcap PLC	Half Year Results
Phoenix Group Holdings PLC	Full Year Results
Stelrad Group PLC	Full Year Results
Tuesday 14 March
Aptamer Group PLC	Half Year Results
Close Brothers Group PLC	Half Year Results
Costain Group PLC	Full Year Results
Eagle Eye Solutions Group PLC	Half Year Results
Genuit Group PLC	Full Year Results
Gresham Technologies PLC	Full Year Results
H&T Group PLC	Full Year Results
Harworth Group PLC	Full Year Results
Litigation Capital Management Ltd	Half Year Results
Midwich Group PLC	Full Year Results
Old Mutual Ltd	Full Year Results
PCI-PAL PLC	Half Year Results
Pennon Group PLC	Trading Statement
Sabre Insurance Group PLC	Full Year Results
Smart Metering Systems PLC	Full Year Results
TP ICAP Group PLC	Full Year Results
Virgin Wines UK PLC	Half Year Results
Yu Group PLC	Full Year Results
Wednesday 15 March
4imprint Group PLC	Full Year Results
Advanced Medical Solutions Group PLC	Full Year Results
Balfour Beatty PLC	Full Year Results
Centaur Media PLC	Full Year Results
FDM Group Holdings PLC	Full Year Results
Ferrexpo PLC	Full Year Results
Foresight Solar Fund Ltd	Full Year Results
IG Group Holdings PLC	Q3 Results
Keywords Studios PLC	Full Year Results
Kin & Carta PLC	Half Year Results
Marshalls PLC	Full Year Results
MaxCyte Inc	Full Year Results
Prudential PLC	Full Year Results
Trainline PLC	Trading Statement

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News

8 May 2019 15:58

MaxCyte begins dosing second cohort in MCY-M11 clinical trial

(Sharecast News) - Clinical-stage, cell-based therapies and life sciences company MaxCyte has initiated dosing for the second cohort of patients in its US phase 1 clinical trial with MCY-M11 - the lead, wholly-owned, non-viral mRNA-based cell therapy candidate from its CARMA platform - it announced on Wednesday.

8 May 2019 12:11

MaxCyte Dosing Second Patients Group In Phase One Cancer Drug Trial

LONDON (Alliance News) - MaxCyte Inc on Wednesday said it has begun dosing for the second cohort of patients in its phase one trial of cancer drug MCY-M11.Shares in MaxCyte were down 5.7% a

24 Apr 2019 11:37

MaxCyte Outlook Confident As Loss Narrows In 2018 On Higher Revenue

LONDON (Alliance News) - MaxCyte Inc on Wednesday said its loss narrowed in 2018 on higher annual fees from its partners as it progresses on MCY-M11 therapeutic candidate development.The a

17 Apr 2019 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 18 April UnileverQ1 ResultsPZ CussonsTrading SolutionsTrading 19 events

8 Apr 2019 13:58

MaxCyte Launches ExPERT Cellular Engineering Technology Platform

LONDON (Alliance News) - MaxCyte Inc on Monday announced the launch of its new ExPERT technology platform for use in cellular engineering.MaxCyte also noted that its business had produced

8 Apr 2019 08:34

MaxCyte launches new generation of cellular engineering instruments

(Sharecast News) - MaxCyte on Monday launched its ExPERT technology platform, a family of instruments that are the next generation of its complex cellular engineering technology.

1 Mar 2019 10:05

MaxCyte Inks Multi-Drug Clinical And Commercial Agreement With Kite

LONDON (Alliance News) - Biotechnology company MaxCyte Inc on Friday said it has expanded its business relationship with Kite by signing a multi-drug clinical and commercial agreement.Under

5 Feb 2019 17:45

UPDATE: MaxCyte Placing Fully Subscribed; Raises Over GBP10.0 Million (ALLISS)

LONDON (Alliance News) - MaxCyte Inc on Tuesday said it has raised GBP10.0 million from a placing of 5.9 million shares at 170 pence each.The life sciences company placed 5.9 million just

5 Feb 2019 10:22

MaxCyte To Raise At Least GBP10 Million For Future Growth Plans (ALLISS)

LONDON (Alliance News) - MaxCyte Inc on Tuesday said it plans to raise at least GBP10 million via a placing of shares in order to accelerate its growth strategy.The life sciences company no

15 Jan 2019 11:18

MaxCyte Guides For Revenue Growth And Earnings Above Expectations

LONDON (Alliance News) - MaxCyte Inc on Tuesday guided for a 19% increase in its 2018 revenue with the firm expecting its annual earnings to exceed market views.The life science company in

24 Oct 2018 16:07

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 25 OctoberGreen & Smart WoodsAlumasc GroupFriday 26 OctoberArgos Capital

10 Oct 2018 11:47

MaxCyte Begins Patient Trial Of Proposed Cancer Treatment MCY-M11

LONDON (Alliance News) - Life sciences and medicines company MaxCyte Inc on Wednesday said it has dosed the first patient in its phase I trial for MCY-M11.MCY-M11 is a mesothelin targeting

24 Sep 2018 10:18

MaxCyte Interim Revenue Rises But Loss Widens On CARMA Development

LONDON (Alliance News) - MaxCyte Inc on Monday said its loss widened in the first half of 2018 as it continued to invest in the development of its CARMA drug platform.The life sciences said

17 Sep 2018 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 18 September Ocado GroupTrading Statement DP PolandHalf Year Year Year Year

26 Jul 2018 17:50

DIRECTOR DEALINGS: Wife Of MaxCyte Non-Executive Director Buys Shares

LONDON (Alliance News) - Medical & technology company MaxCyte Inc said that Karin Johnston, wife of Non-Executive Director John Johnston, purchased 11,500 shares at a price of 240 pence per on

Latest Share Chat

MaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Login to your account

Quickpicks are a member only feature

Login to your account